Skip to main content

MoneyWorks4Me

Kwality Pharmaceuticals informs about annual report

08 Sep 2021 Evaluate
Pursuant to Regulation 34(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Kwality Pharmaceuticals has informed that it enclosed copy of Annual Report for the Financial Year 2020-21 along with notice convening the 38th Annual General Meeting of the members of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1390.50
Cipla 1414.95
Lupin 2010.00
Zydus Lifesciences 1195.05
View more..